Global Age-related Macular Degeneration Market Research Report 2025(Status and Outlook)

March 2025 | 173 pages | ID: GE4AA6B0B6BDEN
Bosson Research

Abstracts

Report Overview

Age-related Macular Degeneration (AMD) is a progressive eye condition that affects the macula, the central part of the retina responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50 in developed countries. AMD can be classified into two types: dry AMD, which involves the gradual breakdown of light-sensitive cells in the macula, and wet AMD, which is characterized by the growth of abnormal blood vessels beneath the macula that leak blood and fluid, causing rapid and severe vision loss. The condition can significantly impact a person's quality of life by impairing their ability to read, drive, recognize faces, and perform daily tasks.

The market for Age-related Macular Degeneration is being primarily driven by the aging population worldwide, as the prevalence of AMD increases with age. In addition, lifestyle factors such as smoking, poor diet, and lack of exercise have been linked to an increased risk of developing AMD, further fueling the market growth. Technological advancements in diagnostic tools and treatment options, such as anti-VEGF drugs for wet AMD, have also contributed to the expansion of the market. Moreover, the rising awareness about the importance of regular eye check-ups and early detection of AMD has led to an increase in the demand for preventive eye care services and products. Overall, the market for AMD is expected to continue growing as the aging population expands and as research and development efforts lead to more effective treatment options.

This report provides a deep insight into the global Age-related Macular Degeneration market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Age-related Macular Degeneration Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Age-related Macular Degeneration market in any manner.

Global Age-related Macular Degeneration Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bayer HealthCare

F. Hoffmann-La Roche

Novartis

Regeneron Pharmaceuticals

Alcon

Allergan

Avalanche

Bausch+Lomb

Gilead Sciences

Iconic Therapeutics

Neurotech Pharmaceuticals

Ohr Pharmaceutical

Market Segmentation (by Type)

Wet AMD

Dry AMD

Market Segmentation (by Application)

Drugstore

Hospital

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Age-related Macular Degeneration Market
• Overview of the regional outlook of the Age-related Macular Degeneration Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-related Macular Degeneration Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Age-related Macular Degeneration
1.2 Key Market Segments
  1.2.1 Age-related Macular Degeneration Segment by Type
  1.2.2 Age-related Macular Degeneration Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 AGE-RELATED MACULAR DEGENERATION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Age-related Macular Degeneration Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Age-related Macular Degeneration Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 AGE-RELATED MACULAR DEGENERATION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Age-related Macular Degeneration Product Life Cycle
3.3 Global Age-related Macular Degeneration Sales by Manufacturers (2020-2025)
3.4 Global Age-related Macular Degeneration Revenue Market Share by Manufacturers (2020-2025)
3.5 Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Age-related Macular Degeneration Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Age-related Macular Degeneration Manufacturing Sites, Area Served, Product Type
3.8 Age-related Macular Degeneration Market Competitive Situation and Trends
  3.8.1 Age-related Macular Degeneration Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Age-related Macular Degeneration Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 AGE-RELATED MACULAR DEGENERATION INDUSTRY CHAIN ANALYSIS

4.1 Age-related Macular Degeneration Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Age-related Macular Degeneration Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Age-related Macular Degeneration Market
5.7 ESG Ratings of Leading Companies

6 AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-related Macular Degeneration Sales Market Share by Type (2020-2025)
6.3 Global Age-related Macular Degeneration Market Size Market Share by Type (2020-2025)
6.4 Global Age-related Macular Degeneration Price by Type (2020-2025)

7 AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-related Macular Degeneration Market Sales by Application (2020-2025)
7.3 Global Age-related Macular Degeneration Market Size (M USD) by Application (2020-2025)
7.4 Global Age-related Macular Degeneration Sales Growth Rate by Application (2020-2025)

8 AGE-RELATED MACULAR DEGENERATION MARKET SALES BY REGION

8.1 Global Age-related Macular Degeneration Sales by Region
  8.1.1 Global Age-related Macular Degeneration Sales by Region
  8.1.2 Global Age-related Macular Degeneration Sales Market Share by Region
8.2 Global Age-related Macular Degeneration Market Size by Region
  8.2.1 Global Age-related Macular Degeneration Market Size by Region
  8.2.2 Global Age-related Macular Degeneration Market Size Market Share by Region
8.3 North America
  8.3.1 North America Age-related Macular Degeneration Sales by Country
  8.3.2 North America Age-related Macular Degeneration Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Age-related Macular Degeneration Sales by Country
  8.4.2 Europe Age-related Macular Degeneration Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Age-related Macular Degeneration Sales by Region
  8.5.2 Asia Pacific Age-related Macular Degeneration Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Age-related Macular Degeneration Sales by Country
  8.6.2 South America Age-related Macular Degeneration Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Age-related Macular Degeneration Sales by Region
  8.7.2 Middle East and Africa Age-related Macular Degeneration Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 AGE-RELATED MACULAR DEGENERATION MARKET PRODUCTION BY REGION

9.1 Global Production of Age-related Macular Degeneration by Region(2020-2025)
9.2 Global Age-related Macular Degeneration Revenue Market Share by Region (2020-2025)
9.3 Global Age-related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Age-related Macular Degeneration Production
  9.4.1 North America Age-related Macular Degeneration Production Growth Rate (2020-2025)
  9.4.2 North America Age-related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Age-related Macular Degeneration Production
  9.5.1 Europe Age-related Macular Degeneration Production Growth Rate (2020-2025)
  9.5.2 Europe Age-related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Age-related Macular Degeneration Production (2020-2025)
  9.6.1 Japan Age-related Macular Degeneration Production Growth Rate (2020-2025)
  9.6.2 Japan Age-related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Age-related Macular Degeneration Production (2020-2025)
  9.7.1 China Age-related Macular Degeneration Production Growth Rate (2020-2025)
  9.7.2 China Age-related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Bayer HealthCare
  10.1.1 Bayer HealthCare Basic Information
  10.1.2 Bayer HealthCare Age-related Macular Degeneration Product Overview
  10.1.3 Bayer HealthCare Age-related Macular Degeneration Product Market Performance
  10.1.4 Bayer HealthCare Business Overview
  10.1.5 Bayer HealthCare SWOT Analysis
  10.1.6 Bayer HealthCare Recent Developments
10.2 F. Hoffmann-La Roche
  10.2.1 F. Hoffmann-La Roche Basic Information
  10.2.2 F. Hoffmann-La Roche Age-related Macular Degeneration Product Overview
  10.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Product Market Performance
  10.2.4 F. Hoffmann-La Roche Business Overview
  10.2.5 F. Hoffmann-La Roche SWOT Analysis
  10.2.6 F. Hoffmann-La Roche Recent Developments
10.3 Novartis
  10.3.1 Novartis Basic Information
  10.3.2 Novartis Age-related Macular Degeneration Product Overview
  10.3.3 Novartis Age-related Macular Degeneration Product Market Performance
  10.3.4 Novartis Business Overview
  10.3.5 Novartis SWOT Analysis
  10.3.6 Novartis Recent Developments
10.4 Regeneron Pharmaceuticals
  10.4.1 Regeneron Pharmaceuticals Basic Information
  10.4.2 Regeneron Pharmaceuticals Age-related Macular Degeneration Product Overview
  10.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Product Market Performance
  10.4.4 Regeneron Pharmaceuticals Business Overview
  10.4.5 Regeneron Pharmaceuticals Recent Developments
10.5 Alcon
  10.5.1 Alcon Basic Information
  10.5.2 Alcon Age-related Macular Degeneration Product Overview
  10.5.3 Alcon Age-related Macular Degeneration Product Market Performance
  10.5.4 Alcon Business Overview
  10.5.5 Alcon Recent Developments
10.6 Allergan
  10.6.1 Allergan Basic Information
  10.6.2 Allergan Age-related Macular Degeneration Product Overview
  10.6.3 Allergan Age-related Macular Degeneration Product Market Performance
  10.6.4 Allergan Business Overview
  10.6.5 Allergan Recent Developments
10.7 Avalanche
  10.7.1 Avalanche Basic Information
  10.7.2 Avalanche Age-related Macular Degeneration Product Overview
  10.7.3 Avalanche Age-related Macular Degeneration Product Market Performance
  10.7.4 Avalanche Business Overview
  10.7.5 Avalanche Recent Developments
10.8 Bausch+Lomb
  10.8.1 Bausch+Lomb Basic Information
  10.8.2 Bausch+Lomb Age-related Macular Degeneration Product Overview
  10.8.3 Bausch+Lomb Age-related Macular Degeneration Product Market Performance
  10.8.4 Bausch+Lomb Business Overview
  10.8.5 Bausch+Lomb Recent Developments
10.9 Gilead Sciences
  10.9.1 Gilead Sciences Basic Information
  10.9.2 Gilead Sciences Age-related Macular Degeneration Product Overview
  10.9.3 Gilead Sciences Age-related Macular Degeneration Product Market Performance
  10.9.4 Gilead Sciences Business Overview
  10.9.5 Gilead Sciences Recent Developments
10.10 Iconic Therapeutics
  10.10.1 Iconic Therapeutics Basic Information
  10.10.2 Iconic Therapeutics Age-related Macular Degeneration Product Overview
  10.10.3 Iconic Therapeutics Age-related Macular Degeneration Product Market Performance
  10.10.4 Iconic Therapeutics Business Overview
  10.10.5 Iconic Therapeutics Recent Developments
10.11 Neurotech Pharmaceuticals
  10.11.1 Neurotech Pharmaceuticals Basic Information
  10.11.2 Neurotech Pharmaceuticals Age-related Macular Degeneration Product Overview
  10.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Product Market Performance
  10.11.4 Neurotech Pharmaceuticals Business Overview
  10.11.5 Neurotech Pharmaceuticals Recent Developments
10.12 Ohr Pharmaceutical
  10.12.1 Ohr Pharmaceutical Basic Information
  10.12.2 Ohr Pharmaceutical Age-related Macular Degeneration Product Overview
  10.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Product Market Performance
  10.12.4 Ohr Pharmaceutical Business Overview
  10.12.5 Ohr Pharmaceutical Recent Developments

11 AGE-RELATED MACULAR DEGENERATION MARKET FORECAST BY REGION

11.1 Global Age-related Macular Degeneration Market Size Forecast
11.2 Global Age-related Macular Degeneration Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Age-related Macular Degeneration Market Size Forecast by Country
  11.2.3 Asia Pacific Age-related Macular Degeneration Market Size Forecast by Region
  11.2.4 South America Age-related Macular Degeneration Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Age-related Macular Degeneration by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Age-related Macular Degeneration Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Age-related Macular Degeneration by Type (2026-2033)
  12.1.2 Global Age-related Macular Degeneration Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Age-related Macular Degeneration by Type (2026-2033)
12.2 Global Age-related Macular Degeneration Market Forecast by Application (2026-2033)
  12.2.1 Global Age-related Macular Degeneration Sales (K Units) Forecast by Application
  12.2.2 Global Age-related Macular Degeneration Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Age-related Macular Degeneration Market Size Comparison by Region (M USD)
Table 5. Global Age-related Macular Degeneration Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Age-related Macular Degeneration Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Age-related Macular Degeneration Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Age-related Macular Degeneration Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2024)
Table 10. Global Market Age-related Macular Degeneration Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Age-related Macular Degeneration Manufacturing Sites and Area Served
Table 12. Manufacturers Age-related Macular Degeneration Product Type
Table 13. Global Age-related Macular Degeneration Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Age-related Macular Degeneration Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Age-related Macular Degeneration Sales by Type (K Units)
Table 25. Global Age-related Macular Degeneration Market Size by Type (M USD)
Table 26. Global Age-related Macular Degeneration Sales (K Units) by Type (2020-2025)
Table 27. Global Age-related Macular Degeneration Sales Market Share by Type (2020-2025)
Table 28. Global Age-related Macular Degeneration Market Size (M USD) by Type (2020-2025)
Table 29. Global Age-related Macular Degeneration Market Size Share by Type (2020-2025)
Table 30. Global Age-related Macular Degeneration Price (USD/Unit) by Type (2020-2025)
Table 31. Global Age-related Macular Degeneration Sales (K Units) by Application
Table 32. Global Age-related Macular Degeneration Market Size by Application
Table 33. Global Age-related Macular Degeneration Sales by Application (2020-2025) & (K Units)
Table 34. Global Age-related Macular Degeneration Sales Market Share by Application (2020-2025)
Table 35. Global Age-related Macular Degeneration Market Size by Application (2020-2025) & (M USD)
Table 36. Global Age-related Macular Degeneration Market Share by Application (2020-2025)
Table 37. Global Age-related Macular Degeneration Sales Growth Rate by Application (2020-2025)
Table 38. Global Age-related Macular Degeneration Sales by Region (2020-2025) & (K Units)
Table 39. Global Age-related Macular Degeneration Sales Market Share by Region (2020-2025)
Table 40. Global Age-related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 41. Global Age-related Macular Degeneration Market Size Market Share by Region (2020-2025)
Table 42. North America Age-related Macular Degeneration Sales by Country (2020-2025) & (K Units)
Table 43. North America Age-related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Age-related Macular Degeneration Sales by Country (2020-2025) & (K Units)
Table 45. Europe Age-related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Age-related Macular Degeneration Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Age-related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 48. South America Age-related Macular Degeneration Sales by Country (2020-2025) & (K Units)
Table 49. South America Age-related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Age-related Macular Degeneration Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Age-related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 52. Global Age-related Macular Degeneration Production (K Units) by Region(2020-2025)
Table 53. Global Age-related Macular Degeneration Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Age-related Macular Degeneration Revenue Market Share by Region (2020-2025)
Table 55. Global Age-related Macular Degeneration Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Age-related Macular Degeneration Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Age-related Macular Degeneration Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Age-related Macular Degeneration Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Age-related Macular Degeneration Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Bayer HealthCare Basic Information
Table 61. Bayer HealthCare Age-related Macular Degeneration Product Overview
Table 62. Bayer HealthCare Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Bayer HealthCare Business Overview
Table 64. Bayer HealthCare SWOT Analysis
Table 65. Bayer HealthCare Recent Developments
Table 66. F. Hoffmann-La Roche Basic Information
Table 67. F. Hoffmann-La Roche Age-related Macular Degeneration Product Overview
Table 68. F. Hoffmann-La Roche Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche SWOT Analysis
Table 71. F. Hoffmann-La Roche Recent Developments
Table 72. Novartis Basic Information
Table 73. Novartis Age-related Macular Degeneration Product Overview
Table 74. Novartis Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Novartis Business Overview
Table 76. Novartis SWOT Analysis
Table 77. Novartis Recent Developments
Table 78. Regeneron Pharmaceuticals Basic Information
Table 79. Regeneron Pharmaceuticals Age-related Macular Degeneration Product Overview
Table 80. Regeneron Pharmaceuticals Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Regeneron Pharmaceuticals Business Overview
Table 82. Regeneron Pharmaceuticals Recent Developments
Table 83. Alcon Basic Information
Table 84. Alcon Age-related Macular Degeneration Product Overview
Table 85. Alcon Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Alcon Business Overview
Table 87. Alcon Recent Developments
Table 88. Allergan Basic Information
Table 89. Allergan Age-related Macular Degeneration Product Overview
Table 90. Allergan Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Allergan Business Overview
Table 92. Allergan Recent Developments
Table 93. Avalanche Basic Information
Table 94. Avalanche Age-related Macular Degeneration Product Overview
Table 95. Avalanche Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Avalanche Business Overview
Table 97. Avalanche Recent Developments
Table 98. Bausch+Lomb Basic Information
Table 99. Bausch+Lomb Age-related Macular Degeneration Product Overview
Table 100. Bausch+Lomb Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Bausch+Lomb Business Overview
Table 102. Bausch+Lomb Recent Developments
Table 103. Gilead Sciences Basic Information
Table 104. Gilead Sciences Age-related Macular Degeneration Product Overview
Table 105. Gilead Sciences Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Gilead Sciences Business Overview
Table 107. Gilead Sciences Recent Developments
Table 108. Iconic Therapeutics Basic Information
Table 109. Iconic Therapeutics Age-related Macular Degeneration Product Overview
Table 110. Iconic Therapeutics Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Iconic Therapeutics Business Overview
Table 112. Iconic Therapeutics Recent Developments
Table 113. Neurotech Pharmaceuticals Basic Information
Table 114. Neurotech Pharmaceuticals Age-related Macular Degeneration Product Overview
Table 115. Neurotech Pharmaceuticals Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Neurotech Pharmaceuticals Business Overview
Table 117. Neurotech Pharmaceuticals Recent Developments
Table 118. Ohr Pharmaceutical Basic Information
Table 119. Ohr Pharmaceutical Age-related Macular Degeneration Product Overview
Table 120. Ohr Pharmaceutical Age-related Macular Degeneration Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Ohr Pharmaceutical Business Overview
Table 122. Ohr Pharmaceutical Recent Developments
Table 123. Global Age-related Macular Degeneration Sales Forecast by Region (2026-2033) & (K Units)
Table 124. Global Age-related Macular Degeneration Market Size Forecast by Region (2026-2033) & (M USD)
Table 125. North America Age-related Macular Degeneration Sales Forecast by Country (2026-2033) & (K Units)
Table 126. North America Age-related Macular Degeneration Market Size Forecast by Country (2026-2033) & (M USD)
Table 127. Europe Age-related Macular Degeneration Sales Forecast by Country (2026-2033) & (K Units)
Table 128. Europe Age-related Macular Degeneration Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Asia Pacific Age-related Macular Degeneration Sales Forecast by Region (2026-2033) & (K Units)
Table 130. Asia Pacific Age-related Macular Degeneration Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. South America Age-related Macular Degeneration Sales Forecast by Country (2026-2033) & (K Units)
Table 132. South America Age-related Macular Degeneration Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Middle East and Africa Age-related Macular Degeneration Sales Forecast by Country (2026-2033) & (Units)
Table 134. Middle East and Africa Age-related Macular Degeneration Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Global Age-related Macular Degeneration Sales Forecast by Type (2026-2033) & (K Units)
Table 136. Global Age-related Macular Degeneration Market Size Forecast by Type (2026-2033) & (M USD)
Table 137. Global Age-related Macular Degeneration Price Forecast by Type (2026-2033) & (USD/Unit)
Table 138. Global Age-related Macular Degeneration Sales (K Units) Forecast by Application (2026-2033)
Table 139. Global Age-related Macular Degeneration Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Age-related Macular Degeneration
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-related Macular Degeneration Market Size (M USD), 2024-2033
Figure 5. Global Age-related Macular Degeneration Market Size (M USD) (2020-2033)
Figure 6. Global Age-related Macular Degeneration Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Age-related Macular Degeneration Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Age-related Macular Degeneration Product Life Cycle
Figure 13. Age-related Macular Degeneration Sales Share by Manufacturers in 2024
Figure 14. Global Age-related Macular Degeneration Revenue Share by Manufacturers in 2024
Figure 15. Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Age-related Macular Degeneration Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Age-related Macular Degeneration Revenue in 2024
Figure 18. Industry Chain Map of Age-related Macular Degeneration
Figure 19. Global Age-related Macular Degeneration Market PEST Analysis
Figure 20. Global Age-related Macular Degeneration Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Age-related Macular Degeneration Market Share by Type
Figure 27. Sales Market Share of Age-related Macular Degeneration by Type (2020-2025)
Figure 28. Sales Market Share of Age-related Macular Degeneration by Type in 2024
Figure 29. Market Size Share of Age-related Macular Degeneration by Type (2020-2025)
Figure 30. Market Size Share of Age-related Macular Degeneration by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Age-related Macular Degeneration Market Share by Application
Figure 33. Global Age-related Macular Degeneration Sales Market Share by Application (2020-2025)
Figure 34. Global Age-related Macular Degeneration Sales Market Share by Application in 2024
Figure 35. Global Age-related Macular Degeneration Market Share by Application (2020-2025)
Figure 36. Global Age-related Macular Degeneration Market Share by Application in 2024
Figure 37. Global Age-related Macular Degeneration Sales Growth Rate by Application (2020-2025)
Figure 38. Global Age-related Macular Degeneration Sales Market Share by Region (2020-2025)
Figure 39. Global Age-related Macular Degeneration Market Size Market Share by Region (2020-2025)
Figure 40. North America Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Age-related Macular Degeneration Sales Market Share by Country in 2024
Figure 43. North America Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Age-related Macular Degeneration Market Size Market Share by Country in 2024
Figure 45. U.S. Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Age-related Macular Degeneration Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Age-related Macular Degeneration Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Age-related Macular Degeneration Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Age-related Macular Degeneration Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Age-related Macular Degeneration Sales Market Share by Country in 2024
Figure 53. Europe Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Age-related Macular Degeneration Market Size Market Share by Country in 2024
Figure 55. Germany Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Age-related Macular Degeneration Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Age-related Macular Degeneration Sales Market Share by Region in 2024
Figure 67. Asia Pacific Age-related Macular Degeneration Market Size Market Share by Region in 2024
Figure 68. China Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Age-related Macular Degeneration Sales and Growth Rate (K Units)
Figure 79. South America Age-related Macular Degeneration Sales Market Share by Country in 2024
Figure 80. South America Age-related Macular Degeneration Market Size and Growth Rate (M USD)
Figure 81. South America Age-related Macular Degeneration Market Size Market Share by Country in 2024
Figure 82. Brazil Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Age-related Macular Degeneration Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Age-related Macular Degeneration Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Age-related Macular Degeneration Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Age-related Macular Degeneration Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Age-related Macular Degeneration Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Age-related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Age-related Macular Degeneration Production Market Share by Region (2020-2025)
Figure 103. North America Age-related Macular Degeneration Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Age-related Macular Degeneration Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Age-related Macular Degeneration Production (K Units) Growth Rate (2020-2025)
Figure 106. China Age-related Macular Degeneration Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Age-related Macular Degeneration Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Age-related Macular Degeneration Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Age-related Macular Degeneration Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Age-related Macular Degeneration Market Share Forecast by Type (2026-2033)
Figure 111. Global Age-related Macular Degeneration Sales Forecast by Application (2026-2033)
Figure 112. Global Age-related Macular Degeneration Market Share Forecast by Application (2026-2033)